Octreotide market: Size, Growth, Regional Analysis, And Market Analysis
Octreotide: Octreotide is a type of hormone medication that is used to treat cancer. It's a long-acting injection used to treat acromegaly and carcinoid tumors in adults, and it's sold under the brand name Sandostatin. The octapeptide class of drugs is sometimes known as the octreotide class. This drug is also used to treat severe watery diarrhea and acute facial reddening. This drug works by inhibiting the production of hormones in the body. Market Growth: The global Octreotide market is estimated to increase at a CAGR of 2.2 per cent from 2021 to 2025, reaching USD 4 million by 2025, up from USD 3 million in the previous forecast period. The octreotide market is expected to rise significantly due to increasing research and development initiatives to develop efficient and cost-effective therapies and introduce new drugs. Furthermore, the increased prevalence of diarrhea and other disorders is a major market driver. However, octreotide market expansion may be hampered by a lac